Related references
Note: Only part of the references are listed.Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP
James B. Bussel et al.
BLOOD (2009)
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura:: a double-blind randomised controlled trial
David J. Kuter et al.
LANCET (2008)
Pharmacodynamics and pharmacokinetics of AMG 531, a thrombopoiesis-stimulating peptibody, in healthy Japanese subjects: A randomized, placebo-controlled study
Yuji Kumagai et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
The pathogenesis of chronic immune thrombocytopenic purpura
Robert McMillan
SEMINARS IN HEMATOLOGY (2007)
An open-label, unit dose-finding study of AMG 531, a novel thrombopoiesis-stimulating peptibody, in patients with immune thrombocytopenic purpura
Adrian Newland et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP
James B. Bussel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
AMG 531: An investigational thrombopoiesis-stimulating peptibody
Janet L. Nichol
PEDIATRIC BLOOD & CANCER (2006)
Management of adult idiopathic thrombocytopenic purpura
DB Cines et al.
ANNUAL REVIEW OF MEDICINE (2005)
Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP
R McMillan et al.
BLOOD (2004)
AMG531 stimulates megakaryopoiesis in vitro by binding to Mp1
VC Broudy et al.
CYTOKINE (2004)
Pharmacodynamics and pharmacokinetics of AMG 531, a novel thrombopoietin receptor ligand
B Wang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro
M Chang et al.
BLOOD (2003)
Effects of pegylated recombinant human megakaryocyte growth and development factor in patients with idiopathic thrombocytopenic purpura
S Nomura et al.
BLOOD (2002)
Medical progress: Immune thrombocytopenic purpura.
DB Cines et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Thrombocytopenia caused by the development of antibodies to thrombopoietin
JZ Li et al.
BLOOD (2001)
Share Paper
